Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica.

Rivera F, Espino AM. Adjuvant-enhanced antibody and cellular responses to inclusion bodies expressing FhSAP2 correlates with protection of mice to Fasciola hepatica. Exp Parasitol. 2016 Jan; 160:31-8.

View in: PubMed

subject areas

Adjuvants, Immunologic
Animals
Antibodies, Helminth
Fasciola hepatica
Fascioliasis
Female
Helminth Proteins
Immunity, Cellular
Immunoglobulin G
Inclusion Bodies
Mice
Mice, Inbred BALB C
Survival Rate
Vaccination

authors with profiles

Ana M. Espino

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support